Apolipoprotein A-I amyloidogenic variant L174S, expressed and isolated from stably transfected mammalian cells, is associated with fatty acids

Amyloid

Volumn 19, Issue 1, 2012, Pages 21-27

  Monti, Daria Maria ^a,b   Di Gaetano, Sonia ^c   Giudice, Rita Del ^a   Giangrande, Chiara ^a   Amoresano, Angela ^a   Monti, Maria ^a,d   Arciello, Angela ^a,b   Piccoli, Renata ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c CNR   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Amyloidosis; ApoA I variants; Apolipoprotein A I; Mass spectrometry; Recombinant amyloidogenic proteins

Indexed keywords

AMYLOID PROTEIN; APOLIPOPROTEIN A1; LEUCINE; MONOUNSATURATED FATTY ACID; RECOMBINANT PROTEIN; SATURATED FATTY ACID; SERINE;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; CULTURE MEDIUM; ELECTROSPRAY MASS SPECTROMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; GENETIC VARIABILITY; MAMMAL CELL; MASS FRAGMENTOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN SECRETION; WILD TYPE;

EID: 84857218604     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2011.651544     Document Type: Article

References (24)

1. Obici L, Franceschini G, Calabresi L, Giorgetti S, Stoppini M, Merlini G, Bellotti V. Structure, function and amyloidogenic propensity of apolipoprotein A-I. Amyloid 2006;13:191-205. (Pubitemid 44764459)
2. Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich PO Jr. Apoproteins B and A-I and coronary artery disease in humans. Arteriosclerosis 1984;4:79-83. (Pubitemid 14152884)
3. Rye KA, Barter PJ. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol 2004;24:421-428. (Pubitemid 38326133)
4. Brouillette CG, Anantharamaiah GM, Engler JA, Borhani DW. Structural models of human apolipoprotein A-I: a critical analysis and review. Biochim Biophys Acta 2001;1531:4-46. (Pubitemid 32241248)
5. Duong PT, Weibel GL, Lund-Katz S, Rothblat GH, Phillips MC. Characterization and properties of pre beta-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I. J Lipid Res 2008;49:1006-1014.
6. Borhani DW, Rogers DP, Engler JA, Brouillette CG. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc Natl Acad Sci U S A 1997;94:12291-12296. (Pubitemid 27492521)
7. Silva RA, Hilliard GM, Fang J, Macha S, Davidson WS. A three-dimensional molecular model of lipid-free apolipoprotein A-I determined by cross-linking/mass spectrometry and sequence threading. Biochemistry 2005;44:2759-2769. (Pubitemid 40293652)
8. Mei X, Atkinson D. Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization. J Biol Chem 2011;286:38570-38582.
9. Obici L, Bellotti V, Mangione P, Stoppini M, Arbustini E, Verga L, Zorzoli I, et al. The new apolipoprotein A-I variant leu(174) Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide. Am J Pathol 1999;155:695-702. (Pubitemid 29426814)
10. Eriksson M, Schönland S, Yumlu S, Hegenbart U, von Hutten H, Gioeva Z, Lohse P, et al. Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene. J Mol Diagn 2009;11:257-262.
11. Di Gaetano S, Guglielmi F, Arciello A, Mangione P, Monti M, Pagnozzi D, Raimondi S, et al. Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potential. Biochem Biophys Res Commun 2006;351:223-228. (Pubitemid 44637274)
12. Monti DM, Guglielmi F, Monti M, Cozzolino F, Torrassa S, Relini A, Pucci P, et al. Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation. Eur Biophys J 2010;39:1289-1299.
13. Arciello A, De Marco N, Del Giudice R, Guglielmi F, Pucci P, Relini A, Monti DM, Piccoli R. Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells. J Cell Mol Med 2011;15:2652-2663.
14. Raimondi S, Guglielmi F, Giorgetti S, Di Gaetano S, Arciello A, Monti DM, Relini A, et al. Effects of the known pathogenic mutations on the aggregation pathway of the amyloidogenic peptide of apolipoprotein A-I. J Mol Biol 2011;407:465-476.
15. Schmidt HH, Haas RE, Remaley A, Genschel J, Strassburg CP, Buttner C, Manns MP. In vivo kinetics as a sensitive method for testing physiologically intact human recombinant apolipoprotein A-I: comparison of three different expression systems. Clin Chim Acta 1997;268:41-60. (Pubitemid 28066801)
16. Mallory JB, Kushner PJ, Protter AA, Cofer CL, Appleby VL, Lau K, Schilling JW, Vigne JL. Expression and characterization of human apolipoprotein A-I in Chinese hamster ovary cells. J Biol Chem 1987;262:4241-4247.
17. Ryan RO, Forte TM, Oda MN. Optimized bacterial expression of human apolipoprotein A-I. Protein Expr Purif 2003;27:98-103. (Pubitemid 37096475)
18. Lagerstedt JO, Cavigiolio G, Roberts LM, Hong HS, Jin LW, Fitzgerald PG, Oda MN, Voss JC. Mapping the structural transition in an amyloidogenic apolipoprotein A-I. Biochemistry 2007;46:9693-9699. (Pubitemid 47328575)
19. Pastore L, Belalcazar LM, Oka K, Cela R, Lee B, Chan L, Beaudet AL. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. Gene 2004;327:153-160. (Pubitemid 38230111)
20. Marchesi M, Parolini C, Valetti C, Mangione P, Obici L, Giorgetti S, Raimondi S, et al. The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: a possible impact on the natural history of the disease. Biochim Biophys Acta 2011;1812:87-93.
21. Pérez-Jiménez F, Castro P, López -Miranda J, Paz-Rojas E, Blanco A, López-Segura F, Velasco F, et al. Circulating levels of endothelial function are modulated by dietary monounsaturated fat. Atherosclerosis 1999;145:351-358. (Pubitemid 29359144)
22. Nordøy A, Goodnight SH. Dietary lipids and thrombosis. Relationships to atherosclerosis. Arteriosclerosis 1990;10:149-163. (Pubitemid 20103577)
23. Yao Y, Eshun JK, Lu S, Berschneider HM, Black DD. Regulation of triacylglycerol and phospholipid trafficking by fatty acids in newborn swine enterocytes. Am J Physiol Gastrointest Liver Physiol 2002;282:G817-G824. (Pubitemid 34651627)
24. Wang H, Berschneider HM, Du J, Black DD. Apolipoprotein secretion and lipid synthesis: regulation by fatty acids in newborn swine intestinal epithelial cells. Am J Physiol 1997;272:G935-G942.